As part of the CROS NT Group global growth strategy, CROS NT acquired MDSL International, a specialist clinical CRO providing biometrics such as clinical data management and statistical services. The financial details were not disclosed.

The U.K. branch of CROS NT sees the acquisition as an important part of the overall group strategy. The deal adds additional resources to the existing group in the U.K. and will provide a new headquarters for the U.K. company in Maidenhead, close to London.

Andrew MacGarvey, CEO and president of CROS NT, said, "We are adding a highly experienced team to the business and further diversifying our customer base, both important objectives of the CROS NT Group. We will move our U.K. headquarters to Maidenhead, giving us a great location in terms of ongoing recruitment and access by our customers given its proximity to London. Coming shortly after our acquisition of Stat-tech Services in the U.S., this deal demonstrates our commitment to place experience close to our customers and to grow to meet the increasing demand for our services."

Edmund Otun, the founder of MDSL International, said, "Being part of a larger entity allows us to provide additional resources to our existing clients, something they have been asking for. CROS NT has a very strong management team, with great experience in the CRO business. I will remain with the company providing consultancy for emerging companies seeking advice on getting their products to market or securing licensing deals."

Jo Marshall, MDSL International managing director, who will become the U.K. country manager for CROS NT, said, " In addition to giving us greater critical mass here in the U.K., this deal will give our existing customers access to the CROS NT technology portfolio, which includes several Electronic Data Capture (EDC) platforms, a Clinical Trial Management System (CTMS) and electronic Patient Reported Outcomes (ePRO) solutions."